Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients

Author:

Coolen-Allou Nathalie1,Touron Thomas1,Belmonte Olivier2,Gazaille Virgile1,Andre Michel1,Allyn Jérôme3,Picot Sandrine4,Payet Annabelle5,Veziris Nicolas67

Affiliation:

1. Service de Pneumologie, CHU La Réunion Site Félix Guyon, Saint Denis, France

2. Service de Microbiologie, CHU La Réunion Site Félix Guyon, Saint Denis, France

3. Service de Réanimation Médicale, CHU La Réunion Site Félix Guyon, Saint Denis, France

4. Service de Microbiologie, CHU La Réunion Site Sud Réunion, Saint Pierre, France

5. Service de Pneumologie, CHU La Réunion Site Sud Réunion, Saint Pierre, France

6. Sorbonne Universités, UPMC Universitaire de Paris 06, INSERM, Centre d'Immunologie et des Maladies Infectieuses, UMR 1135, Paris, France

7. Département de Bactériologie, Hôpitaux Universitaires de l'Est Parisien, Centre National de Référence des Mycobactéries, Assistance Publique-Hôpitaux de Paris, Paris, France

Abstract

ABSTRACT Mycobacterium simiae is a rare species of slow-growing nontuberculous mycobacteria (NTM). From 2002 to 2017, we conducted a retrospective study that included all patients with NTM-positive respiratory samples detected in two university hospitals of the French overseas department of Reunion Island. We recorded the prevalence of M. simiae in this cohort, as well as the clinical, radiological, and microbiological features of patients with at least 1 sample positive for M. simiae . In our cohort, 97 patients (15.1%) were positive for M. simiae . Twenty-one patients (21.6%) met the American Thoracic Society (ATS) criteria for infection. M. simiae infection was associated with bronchiectasis, micronodular lesions, and weight loss. Antibiotic susceptibility testing was performed for 60 patients, and the isolates were found to have low susceptibility to antibiotics, except for amikacin, fluoroquinolones, and clarithromycin. Treatment failed for 4 of the 8 patients treated for M. simiae infection. Here, we describe a specific cluster corresponding to a large cohort of patients with M. simiae , a rare nontuberculous mycobacterium associated with low pathogenicity and poor susceptibility to antibiotics.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3